FCVFX
Price
$28.03
Change
+$0.29 (+1.05%)
Updated
Apr 17 closing price
Net Assets
333.12M
MVCAX
Price
$27.72
Change
+$0.25 (+0.91%)
Updated
Apr 17 closing price
Net Assets
15.41B
Ad is loading...

FCVFX vs MVCAX

Header iconFCVFX vs MVCAX Comparison
Open Charts FCVFX vs MVCAXBanner chart's image
Fidelity Advisor Value C
Price$28.03
Change+$0.29 (+1.05%)
VolumeN/A
Net Assets333.12M
MFS Mid Cap Value A
Price$27.72
Change+$0.25 (+0.91%)
VolumeN/A
Net Assets15.41B
FCVFX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FCVFX vs. MVCAX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCVFX is a Buy and MVCAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 15.4B vs. FCVFX (333M). MVCAX pays higher dividends than FCVFX: MVCAX (0.90) vs FCVFX (0.00). FCVFX was incepted earlier than MVCAX: FCVFX (21 years) vs MVCAX (24 years). FCVFX (1.96) is less costly to investors than MVCAX (1.00). FCVFX is a more actively managed with annual turnover of: 80.00 vs. MVCAX (27.00). FCVFX has a lower initial minimum investment than MVCAX: FCVFX (0) vs MVCAX (1000). MVCAX annual gain was more profitable for investors over the last year : -8.14 vs. FCVFX (-17.37). FCVFX return over 5 years is better than : 83.67 vs. MVCAX (54.79).
FCVFXMVCAXFCVFX / MVCAX
Total Expense Ratio1.900.99192%
Annual Report Gross Expense Ratio1.961.00196%
Fund Existence21 years24 years-
Gain YTD-13.744-9.648142%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets333M15.4B2%
Annual Yield % from dividends0.000.90-
Returns for 1 year-17.37-8.14213%
Returns for 3 years-10.17-6.94147%
Returns for 5 years83.6754.79153%
Returns for 10 years27.5542.2765%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USEMX19.85N/A
N/A
Victory Emerging Markets
HCAYX48.81N/A
N/A
Hartford Capital Appreciation Y
SPVZX22.09N/A
N/A
PGIM Quant Solutions Mid-Cap Val Z
GEMLX11.14N/A
N/A
Goldman Sachs Emerging Mkts Eq ex. Chn C
CGRIX59.94-0.22
-0.37%
Calamos Growth I